Merk, H.; Amran-Gealia, T.; Finkelmeier, D.; Kohl, C.; Pichota, I.; Stern, N.; Rupp, S.; Goldblum, A.; Burger-Kentischer, A.
Human-Based Immune Responsive In Vitro Infection Models for Validation of Novel TLR4 Antagonists Identified by Computational Discovery. Microorganisms 2022, 10, 243.
https://doi.org/10.3390/microorganisms10020243
AMA Style
Merk H, Amran-Gealia T, Finkelmeier D, Kohl C, Pichota I, Stern N, Rupp S, Goldblum A, Burger-Kentischer A.
Human-Based Immune Responsive In Vitro Infection Models for Validation of Novel TLR4 Antagonists Identified by Computational Discovery. Microorganisms. 2022; 10(2):243.
https://doi.org/10.3390/microorganisms10020243
Chicago/Turabian Style
Merk, Helena, Tehila Amran-Gealia, Doris Finkelmeier, Christina Kohl, Isabelle Pichota, Noa Stern, Steffen Rupp, Amiram Goldblum, and Anke Burger-Kentischer.
2022. "Human-Based Immune Responsive In Vitro Infection Models for Validation of Novel TLR4 Antagonists Identified by Computational Discovery" Microorganisms 10, no. 2: 243.
https://doi.org/10.3390/microorganisms10020243
APA Style
Merk, H., Amran-Gealia, T., Finkelmeier, D., Kohl, C., Pichota, I., Stern, N., Rupp, S., Goldblum, A., & Burger-Kentischer, A.
(2022). Human-Based Immune Responsive In Vitro Infection Models for Validation of Novel TLR4 Antagonists Identified by Computational Discovery. Microorganisms, 10(2), 243.
https://doi.org/10.3390/microorganisms10020243